The U.S. Fertility Market Is Expected To Reach Revenue Of Usd 8.7 Bn By 2033, At 5.1% CAGR: Dimension Market Research
December 09, 2024 09:01 ET
|
Dimension Market Research
New York, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Overview The U.S. Fertility Market is projected to reach USD 5.6 billion in 2024 which is further anticipated to reach USD 8.7 billion by 2033 at a CAGR...
Intrauterine Devices Market Report Forecasts and Company Analysis 2024-2032, Profiles of AbbVie, Bayer, Teva Pharmaceuticals, ANI Pharmaceuticals, Mylan, CooperSurgical. and DKT International
December 04, 2024 07:38 ET
|
Research and Markets
Dublin, Dec. 04, 2024 (GLOBE NEWSWIRE) -- The "Intrauterine Devices Market Report Forecast by Type, End-use, Countries and Company Analysis 2024-2032" report has been added to ...
Male Infertility Business Research Report 2024: Global Market to Reach $6.5 Billion by 2030 - Focus on Reducing Stigma and Increasing Access Strengthens Growth Prospects
November 19, 2024 09:04 ET
|
Research and Markets
Dublin, Nov. 19, 2024 (GLOBE NEWSWIRE) -- The "Male Infertility - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Male Infertility...
2024 Research Report | Contraceptive Drugs Market Poised for Expansion, Predicted to Reach USD 12.47 Billion by 2030
October 30, 2024 11:28 ET
|
Research and Markets
Dublin, Oct. 30, 2024 (GLOBE NEWSWIRE) -- The "Contraceptive Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's...
Myriad Genetics and jscreen™ Announce Strategic Partnership to Advance Health Equity and Genetic Testing Access
October 16, 2024 09:00 ET
|
Myriad Genetics, Inc.
Myriad Genetics announced a strategic partnership with jscreen to advance health equity and genetic testing access.
Women’s Health Therapeutics Market Size to Reach USD 61.6 Billion by 2032, Driven by Rising Awareness & Technological Advancements - SNS Insider
October 15, 2024 09:10 ET
|
SNS Insider pvt ltd
Pune, Oct. 15, 2024 (GLOBE NEWSWIRE) -- According to SNS Insider, The Women’s Health Therapeutics Market was estimated to be USD 43.21 billion in 2023 and is projected to be valued at USD 61.6...
£302+ Million UK Pregnancy Testing Kits Market Forecast, 2029: Heightened Awareness, Convenience, and Technological Innovations Driving Industry Growth, Dominated by the South-East
October 10, 2024 04:17 ET
|
Research and Markets
Dublin, Oct. 10, 2024 (GLOBE NEWSWIRE) -- The "United Kingdom Pregnancy Testing Kits Market, By Region, Competition, Forecast & Opportunities, 2019-2029F" report has been added to ...
Pregnancy Detection Kits Industry Report 2024, Featuring Key Players Alere, Church & Dwight, Confirm BioSciences, CVS Health, Mankind Pharma, Philippine Blue Cross Biotech, Prestige Brands and Quidel
October 08, 2024 04:03 ET
|
Research and Markets
Dublin, Oct. 08, 2024 (GLOBE NEWSWIRE) -- The "Pregnancy Detection Kits - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Pregnancy...
Mifepristone and Misoprostol are Not “Controlled Dangerous Substances”: The American College of Medical Toxicology Issues Position Statement
September 30, 2024 11:29 ET
|
American College of Medical Toxicology
Phoenix, AZ, Sept. 30, 2024 (GLOBE NEWSWIRE) -- In May of 2024, Louisiana enacted a law classifying mifepristone and misoprostol as Schedule IV controlled dangerous substances, akin to medications...
U.S. Women's Health Market Size, Share & Trends Analysis Report 2024-2030: Hormonal Infertility, Contraceptives, Postmenopausal Osteoporosis, Endometriosis & Uterine Fibroids, Menopause, PCOS
September 20, 2024 04:04 ET
|
Research and Markets
Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The "U.S. Women's Health Market Size, Share & Trends Analysis Report By Application (Contraceptives, Endometriosis & Uterine Fibroids), By Age (50...